We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.26%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$5.92B
AUM Growth
+$1.77B
Cap. Flow
+$1.61B
Cap. Flow %
27.24%
Top 10 Hldgs %
29.35%
Holding
6,215
New
374
Increased
3,547
Reduced
1,424
Closed
549

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$87.5M
2
AAPL icon
Apple
AAPL
+$68.6M
3
AMZN icon
Amazon
AMZN
+$62.8M
4
META icon
Meta Platforms (Facebook)
META
+$41.4M
5
AMD icon
Advanced Micro Devices
AMD
+$39.4M

Sector Composition

Rank Sector Weight
1 Technology 29.49%
2 Consumer Discretionary 9.8%
3 Financials 9.15%
4 Healthcare 9.12%
5 Communication Services 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AKTS
4326
DELISTED
Akoustis Technologies Inc
AKTS
$8.61K ﹤0.01%
65,258
+47,972
+278% +$18.1K
APCX
4327
DELISTED
AppTech Payments
APCX
$8.61K ﹤0.01%
9,162
+5,443
+146% +$4.96K
AXDX
4328
DELISTED
Accelerate Diagnostics
AXDX
$8.61K ﹤0.01%
7,359
-898
-11% -$938
JAGX icon
4329
Jaguar Health
JAGX
$4.1M
$8.6K ﹤0.01%
3
+2
+200% +$13.2K
MTEX icon
4330
Mannatech
MTEX
$9.46M
$8.6K ﹤0.01%
1,266
-241
-16% -$1.87K
VCNX
4331
DELISTED
Vaccinex, Inc. Common Stock
VCNX
$8.59K ﹤0.01%
1,324
+279
+27% +$1.69K
COCP icon
4332
Cocrystal Pharma
COCP
$14.9M
$8.58K ﹤0.01%
3,681
-3,775
-51% -$7.36K
BIVI icon
4333
BioVie
BIVI
$8.3M
$8.57K ﹤0.01%
214
+91
+74% +$4.36K
SDPI
4334
DELISTED
Superior Drilling Products Inc.
SDPI
$8.57K ﹤0.01%
6,593
-704
-10% -$856
ICCC icon
4335
ImmuCell
ICCC
$99.2M
$8.57K ﹤0.01%
1,767
-236
-12% -$1.14K
EFAV icon
4336
iShares MSCI EAFE Min Vol Factor ETF
EFAV
$5.48B
$8.53K ﹤0.01%
123
+8
+7% +$562
AUUD
4337
Auddia
AUUD
$7.08M
$8.53K ﹤0.01%
67
+43
+179% +$8.75K
SJT
4338
San Juan Basin Royalty Trust
SJT
$121M
$8.53K ﹤0.01%
2,100
+1,416
+207% +$6.22K
RMBI icon
4339
Richmond Mutual Bancorp
RMBI
$254M
$8.52K ﹤0.01%
726
+701
+2,804% +$8.07K
XMAX
4340
XMAX Inc
XMAX
$585M
$8.52K ﹤0.01%
5,229
+660
+14% +$1.41K
DSS icon
4341
DSS Inc
DSS
$5.12M
$8.52K ﹤0.01%
4,953
-123
-2% -$218
LOAN
4342
Manhattan Bridge Capital
LOAN
$47.6M
$8.51K ﹤0.01%
1,655
-1,501
-48% -$7.68K
NB
4343
NioCorp Developments
NB
$793M
$8.51K ﹤0.01%
4,917
+1,451
+42% +$3.38K
ADN
4344
DELISTED
Advent Technologies
ADN
$8.49K ﹤0.01%
2,784
+1,664
+149% +$6.53K
INKT icon
4345
MiNK Therapeutics
INKT
$54.6M
$8.49K ﹤0.01%
895
-211
-19% -$2.05K
FBRX icon
4346
Forte Biosciences
FBRX
$1.57B
$8.48K ﹤0.01%
632
+166
+36% +$2.68K
SOHU
4347
Sohu.com
SOHU
$376M
$8.48K ﹤0.01%
609
+183
+43% +$2.2K
IZEA icon
4348
IZEA Worldwide
IZEA
$62.7M
$8.48K ﹤0.01%
3,607
+1,226
+51% +$3.14K
NTIP icon
4349
Network-1 Technologies
NTIP
$36.1M
$8.47K ﹤0.01%
4,761
+1,564
+49% +$2.88K
IX icon
4350
ORIX
IX
$43.3B
$8.46K ﹤0.01%
380
-1,415
-79% -$30.2K

Similar funds

Tower Research Capital (TRC)'s Q2 2024 Portfolio in Review

As of Q2 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.92B, up 43% from $4.15B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.61B of net new capital in Q2 2024, opening 374 new positions and adding to 3,547 existing holdings. Its largest new stake was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $158M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2024 buy was State Street Financial Select Sector SPDR ETF: 480,124 shares worth $19.7M.
  • Tower Research Capital (TRC) added most to Microsoft in Q2 2024, an estimated $87.5M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $158M.
  • Tower Research Capital (TRC) fully exited iShares Core S&P Mid-Cap ETF in Q2 2024, selling an estimated $18.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.92B portfolio in Q2 2024.
  • Tower Research Capital (TRC) opened 374 new positions and closed 549 in Q2 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 43% quarter-over-quarter to $5.92B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.